Keynote

  • Prof. Dr. Yoshio Katakura

    Kansai University, Japan

    Topics: Efficient production of lactic acid bacteria by aerobic fed-batch culture

  • Prof. Dr. Seppo Salminen

    University of Turku, Finland

    Topics: ‘Biotic’ family: definitions and future perspectives

Symposium 1~6

Symposium 1．Next Probiotics and Immune Function

  • Prof. Dr. Haruki Kitazawa

    Graduate School of Agricural Science, Tohoku University. Japan

    Topics: Antiviral immunobiotics and immunopostbiotics: promising alternatives to combat viral infectious diseases

  • Prof. Dr. Linzhu Ren

    College of Animal Sciences, Jilin University，China

    Topics: A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2

  • Prof. Dr. Sin-Hyeog Im

    Department of Life Sciences, Pohang University of Science and Technology, Korea

    Topics: Probiotics at the Boundary of Functional Food and Therapeutics

  • Prof. Dr. Hooi-Ling Foo

    Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Malaysia

    Topics: Futuristic Probiotics

Symposium 2．Gut Microbiota and Maternal & Infant Health

  • Prof. Dr. Yuan Kun Lee

    Yong Loo Lin School of Medicine, National University of Singapore, Singapore

    Topics: Origin & Establishment of Gut Microbiome in Early Life, Their Roles in Health & Diseases

  • Dr. Takahiro Matsuki

    Yakult Central Institute, Japan

    Topics: Dynamics and individual variation of gut short-chain fatty acid profiles and their association with microbiota in early life

  • Prof. Dr. Takane Katayama

    Kyoto University, Japan

    Topics: Adaptive strategy of bifidobacteria to assimilate human milk oligosaccharides in breastfed infant gut

  • Dr. Jong-Won Yoon

    Advanced Protein Technologies, Korea

    Topics: Health benefits of Human milk oligosaccharides (HMOs) and commercialization of 2′-fucosyllactose (2′-FL)

Symposium 3．Food and Microbiota and Health

  • Assoc. Prof. Dr. Takashi Koyanagi

    Department of Food Science, Ishikawa Prefectural University, Japan

    Topics: Microbial diversity and robustness behind the fermentation process of traditional foods in Japan

  • Assist. Professor Dr. Massalin Nakphaichit

    Faculty of Agro-Industry, Kasetsart University, Thailand

    Topics: The effect of different doses of copra meal hydrolysate on gut health

  • Prof. Dr. Jyoti Prakash Tamang

    Department of Microbiology, Sikkim University, India

    Topics: Probiotic bacteria and their genetic screening in the naturally fermented milk products of the Himalayas

  • Prof. Dr. Qing Gu

    School of Food and Biotechnology, Zhejiang Gongshang University, China

    Topics: Antibacterial mode of action of a lactic acid bacteria-derived bacteriocin and its modulation effect on intestinal flora

Symposium 4．Interaction of Probiotics and Prebiotics

  • Prof. Dr. Naoyuki Yamamoto

    School of Life Science and Technplogy, Tokyo Institute of Technology, Japan

    Topics: Screen of gut proteins with affinity to intestinal bacteria

  • Prof. Dr. Seyed Abbas Shojaosadati

    Tarbiat Modares University, Iran

    Topics: The Development of New Antimicrobial Bionanocomposite based on the Synbiotic–Nanoparticle System

  • Assist. Professor Dr. Weitao Geng

    Tianjin University of Science & Technology, China

    Topics: CRISPR/Cas9(D10A)-Assisted Genome Editing in Lactobacillus kefiranofaciens and Its Application in Exopolysaccharide Production

  • Dr. Yong-Ha Park

    ProBionic Institute and Probiotics House, Korea

    Topics: Antiviral Probiotics: A new probiotic paradigm with Therapeutic implications of Respiratory disease including COVID-19

Symposium 5．Microbial Metabolite and Cross-talk of Gut microbiota

  • Prof. Dr. Jiro Nakayama

    Faculty of Agriculture, Kyushu University, Japan

    Topics: Gut microbiome and metabolome of Asian population related to diet and health

  • Prof. Dr. Atsushi Yokota

    Graduate school of Agriculture, Hokkaido Univiersity, Japan

    Topics: Gut microbiota and host health as revealed by the interaction between bile acids and gut microbes

  • Dr. Mitsuharu Matsumoto

    Dairy Science and Technology Institute, Kyodo Milk Industry Co. Ltd., Japan

    Topics: Functions of polyamines produced by intestinal microbiome

  • Prof. Dr. Ming-Ju Chen

    Department of Animal Science and Technology, National Taiwan University, Taiwan

    Topics: Targeting the gut microbiome as a treatment for cardiovascular diseases

  • Dr. Ratha Mahendran

    Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

    Topics: Microbes and the host response to drugs

  • Assoc. Prof. Dr. Keita Nishiyama

    Keio University School of Medicine, Japan

    Topics: Microbes and the host response to drugs

Symposium 6．Pre, Pro, Postbiotics and New Technology

  • Prof. Dr. Koichi Watanabe

    National Taiwan University, Taiwan

    Topics: Genome-based taxonomy of the “Lactobacillus”

  • Prof. Dr. Akihito Endo

    Tokyo Univerisity of Agriculture, Japan

    Topics: Fructooligosaccharide metabolism in human commensal butyrate producers

  • Prof. Dr. Miguel Gueimonde

    Institute of Dairy Products of Asturias, Spanish National Research Council, Spain

    Topics: Use of in vitro fecal culture for the screening and selection of probiotics and prebiotics for specific population groups: obesity as an example

  • Prof. Dr. Endang Rahayu

    Gadjah Mada University, Indonesia

    Topics: Probiotic and dietary approaches for asymptomatic covid-19 patients

  • Prof. Dr. Francisco Elegado

    University of Philippines Los Baños, Philippine

    Topics: Plant-based LAB for the Development of Non-Dairy Probiotics

  • Prof. Dr. Erdene Bayar

    Institute of Veterinary Medicine, Mongolian University of Life Science, Mongolia

    Topics: Antimicrobial peptides produced by bifidobacteria in infant lamb

Special Symposium：Gut-Brain Axis

  • Prof. Dr. Ying-Chien Tsai, Taiwan

    National Yang Ming Chiao Tung University, Taiwan

    Topics: Psychobiotics for Parkinson’s Disease

  • Prof. Dr. MinTze Liong, Malaysia

    University Sains Malaysia, Malaysia

    Topics: Gut & Brain: A view from the perspectives of gut microbiota

  • Dr. Jinzhong Xiao

    Morinaga Milk Industry Co., Ltd., Japan

    Topics: Translation of preclinical studies to human intervention: Potential of Bifidobacterium breve strain in improving cognitive functions

Program of ACLAB11

*Time is represented as Japan time.

Nov 4 (Thursday)：　IEBC meeting

Nov 5 (Friday)

Channel 1

  • 10:30-10:50(0:20)

    Opening Ceremony

  • 10:50-11:30(0:40)

    Keynote Lecture 1: Efficient production of lactic acid bacteria by aerobic fed-batch culture
    (Chair: Dr. Atsushi Yokota)

    • Prof. Yoshio Katakura Kansai University, Japan

  • 11:30-11:45(0:15)

    Break Time

  • 11:45-13:25(1:40)

    Symposium 1 (20+5′ x 4): Next Probiotics and Immune Function
    (Chair: Dr. Haruki Kitazawa, Dr. Hooi-Ling Foo)

    • S1-1. Antiviral immunobiotics and immunopostbiotics: promising alternatives to combat viral infectious diseases
      Prof. Dr. Haruki Kitazawa Tohoku University, Japan
    • S1-2. A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2
      Prof. Dr. Linzhu Ren Jilin University，China
    • S1-3. Probiotics at the Boundary of Functional Food and Therapeutics
      Prof. Dr. Sin-Hyeog Im Pohang University of Science and Technology, Korea
    • S1-4. Futuristic Probiotics
      Prof. Dr. Hooi-Ling Foo Universiti Putra Malaysia, Malaysia

  • 13:25-13:35(0:10)

    Break Time

  • 13:35-14:59(1:24)

    “Oral presentation 1 (10+4′ x 6): Fermentation and Genetics
    (Chair: Dr. Katsunori Kimura, Dr. Satoru Fukiya)

    • O1-1. Functional analysis of the biosynthesis genes of the multiple bacteriocins produced by Lactobacillus plantarum PUK6 isolated from tofu pickled in miso
      Ai Kawahara Prefecture University of Kumamoto, Japan
    • O1-2. Insertion sequences in Tetragenococcus halophilus
      Takura Wakinaka Yamasa Corporation, Japan
    • O1-3. Programming lactic acid bacteria for cancer therapy : a part genetic toolbox
      Elsa FRISTOT University of Montpellier, France
    • O1-4. Study of Cambodian Small Cucumber Fermentation by Three Different Methods
      Reasmey Tan Institute of Technology of Cambodia, Cambodia
    • O1-5. The effects of incorporation of chili, turmeric and black pepper at different concentrations on microbiological quality and sensory acceptance of fermented Tilapia nicoliticus
      Mohd Nizam Lani Universiti Malaysia Terengganu, Malaysia
    • O1-6. Improvement of Protein Quality of Composite Flour via Biotransformation Process Mediated by Lactiplantibacillus plantarum RS-5
      Koyum Adebayo Kareem Universiti Putra Malaysia, Malaysia

  • 14:59-15:10(0:11)

    Break Time

  • 15:10-16:48(1:38)

    “Oral presentation 3 (10+4′ x 7) Food, Function, and Micobiome
    (Chair: Dr. Takashi Kuda , Dr. Shino Yamasaki)

    • O3-1. Characteristics and potential biological activity of peptides released by Lactic Acid Bacteria in fermented milk: Antihypertensive and Antioxidant Peptides
      Yuliana Tandi Rubak Universitas Nusa Cendana, Indonesia
    • O3-2. Edible swiftlet’s nest (ESN) and bioactive ESN glycopeptide hydrolysate as a potential prebiotic stimulates the growth of human colonic probiotics
      Hui Yan Tan, Putra University of Malaysia, Malaysia
    • O3-3. Effect of sago starch on colonic bacteria
      Kathleen Michelle Mikal Universiti Putra Malaysia, Malaysia
    • O3-4. Effect of Streptococcus thermophilus on intestinal microbiota depends on distinctions of strains
      Peng Yu Jiangnan University, China
    • O3-5. The role of priority effects in the formation of infant-gut associated Bifidobacterium communities
      Miriam Nozomi Ojima Kyoto University, Japan
    • O3-6. Investigation of microorganism communication in kefir grains by analyzing metabolome and microbiome in different substrates
      De-Rong chih National Taiwan University, Taiwan
    • O3-7. Can Lactic Acid Bacteria Produce Extracellular Xylanase?
      Noor Lutphy Ali Universiti Putra Malaysia, Malaysia

  • 16:48-17:00(0:12)

    Break Time

  • 17:00-18:40(1:40)

    “Symposium 3 (20+5′ x 4): Food and Microbiota and Health
    (Chair: Dr. Takashi Koyanagi, Dr. Jyoti Prakash Tamang)

    • S3-1. Microbial diversity and robustness behind the fermentation process of traditional foods in Japan
      Ass. Prof Dr. Takashi Koyanagi Ishikawa Prefectural University, Japan
    • S3-2. The effect of different doses of copra meal hydrolysate on gut health
      Prof. Dr. Massalin Nakphaichit Kasetsart University, Thailand
    • S3-3. Probiotic bacteria and their genetic screening in the naturally fermented milk products of the Himalayas
      Prof. Dr. Jyoti Prakash Tamang Sikkim University, India
    • S3-4. Antibacterial mode of action of a lactic acid bacteria-derived bacteriocin and its modulation effect on intestinal flora
      Prof. Dr. Qing Gu Zhejiang Gongshang University, China

  • 18:40-19:00(0:20)

    Break Time

  • 19:00-21:00(2:00)

    Web Party

Channel 2

  • 11:45-13:25(1:40)

    Symposium 2 (20+5′ x 4) Gut Microbiota and Maternal & Infant Health
    (Chair: Dr. Takahiro Matsuki, Dr. Lee Yuan Kun)

    • S2-1. Origin & Establishment of Gut Microbiome in Early Life, Their Roles in Health & Diseases
      Prof. Lee Yuan Kun National University of Singapore, Singapore
    • S2-2. Dynamics and individual variation of gut short-chain fatty acid profiles and their association with microbiota in early life
      Dr. Takahiro Matsuki Yakult Central Institute, Japan
    • S2-3. Adaptive strategy of bifidobacteria to assimilate human milk oligosaccharides in breastfed infant gut
      Prof. Dr. Takane Katayama Kyoto University, Japan
    • S2-4. Health benefits of Human milk oligosaccharides (HMOs) and commercialization of 2′-fucosyllactose (2′-FL)
      Dr. Jong-Won Yoon Advanced Protein Technologies, Korea”

  • 13:25-13:35(0:10)

    Break Time

  • 13:35-14:59(1:24)

    Oral presentation 2 (10+4′ x 6): Probiotics, Prebiotics, and Postbiotics
    (Chair: Dr. Hidehori Shimidzu, Dr. Shin Kurihara)

    • O2-1. Functional and genomic characterization of immunobiotic lactobacilli for immunosynbiotic development
      Binghui Zhou Tohoku University, Japan
    • O2-2. Immunomodulatory effects of lactobacilli from green tea leaf in murine macrophages and intestinal epithelial cells: the role of bacterial RNA
      Masahiko Suzuki ITO EN Ltd., Japan
    • O2-3. Direct and immune-mediated anti-cancer activities of cell-free supernatant from a locally-isolated lactic acid bacteria strain in the Philippines
      Ranelle Janine Llanes Asi University of the Philippines Diliman, Philippine
    • O2-4. Immunostimulatory mechanism mediated by membrane vesicles released by Latilactobacillus sakei
      Keiko Nishimura Kansai University, Japan
    • O2-5. Production optimization, primary structural characterization and antioxidative assay of exopolysaccharides produced by Pediococcus pentosaceus FFC003 isolated from traditional Miso in Japan
      Junliang Zhao Okayama University, Japan
    • O2-6. Leuconostoc mesenteroides M048 exopolysaccharides exert health benefits as prebiotics
      Hidenori Shimizu Noster Inc., Japan

  • 14:59-15:10(0:11)

    Break Time

  • 15:10-16:48(1:38)

    Oral presentation 4 (10+4′ x 7): Host-Microbe Interaction
    (Chair: Dr. Tomoyuki Nakagawa, Dr. Toshitaka Odamaki)

    • O4-1. Comparison of gut microbiota between diabetic and non-diabetic obese Mongolian
      Akari Shinoda Kyushu University, Japan
    • O4-2. ITS2 sequencing and targeted meta-proteomics of infant gut mycobiome reveal the functional role of Rhodotorula sp. during atopic dermatitis manifestation
      Kevin Mok Kasetsart University, Thailand
    • O4-3. Physiological and genomic analysis of forgotten secondary bile acid producer Eubacterium sp. c-25
      Isaiah Song Hokkaido University, Japan
    • O4-4. Improving the Gut-Brain Axis by Probiotics in Neurodegenerative Disorders
      Maryam Tajabadi Ebarahimi Islamic Azad University, Iran
    • O4-5. In vitro and in vivo anti-Campylobacter jejuni DC3 activity of Lactobacillus sakei L14 isolated from chicken intestine
      Ma. Socorro Edden Subejano University of the Philippines Diliman, Philippine
    • O4-6. Strain-specific effects of Bifidobacterium longum on hypercholesterolemic rats and potential mechanisms
      Jinchi Jiang Nanjing Tech University, China
    • O4-7. Carbohydrate-binding module-dependent mucin degradation by Bifidobacterium bifidum
      Toshihiko Katoh Kyoto University, Japan

  • 16:48-17:00(0:12)

    Break Time

  • 17:00-18:40(1:40)

    Symposium 4 (20+5′ x 4): Interaction of Probiotics and Prebiotics
    Chair: (Dr. Naoyuki Yamamoto, Dr. Yong-Ha Park)

    • S4-1. Screen of gut proteins with affinity to intestinal bacteria
      Prof. Dr. Naoyuki Yamamoto Tokyo Institute of Technology, Japan
    • S4-2. The Development of New Antimicrobial Bionanocomposite based on the Synbiotic–Nanoparticle System
      Prof. Dr. Seyed Abbas Shojaosadati Tarbiat Modares University, Iran
    • S4-3. CRISPR/Cas9(D10A)-Assisted Genome Editing in Lactobacillus kefiranofaciens and Its Application in Exopolysaccharide Production
      Assist. Professor Dr.Weitao Geng Tianjin University of Science & Technology, China
    • S4-4. Antiviral Probiotics: A new probiotic paradigm with Therapeutic implications of Respiratory disease including COVID-19
      Dr. Yong-Ha Park ProBionic Institute and Probiotics House, Korea

  • 18:40-19:00(0:20)

    Break Time

  • 19:00-21:00(2:00)

    Web Party

Nov 6 (Saturday)

Channel 1

  • 10:30-12:00(1:30)

    Special Symposium (25+5′ x 3): Gut-Brain Axis
    (Chair: Dr. Jinzhong Xiao, Dr. MinTze Liong)

    • SS-1.Psychobiotics for Parkinson’s Disease
      Prof. Dr. Ying-Chien Tsai National Yang Ming Chiao Tung University, Taiwan
    • SS-2. Gut & Brain: A view from the perspectives of gut microbiota
      Prof. Dr. MinTze Liong University Sains Malaysia, Malaysia
    • SS-3. Translation of preclinical studies to human intervention: Potential of Bifidobacterium breve strain in improving cognitive functions
      Dr. Jinzhong Xiao Morinaga Milk Industry Co., Ltd., Japan

  • 12:00-12:15(0:15)

    Break Time

  • 12:15-13:39(1:24)

    Oral presentation 5 (10+4′ x 6) Probiotics/Prebiotics/Postbiotics
    (Chair: Dr. Gaku Harata, Dr. Takeshi Shimosato)

    • O5-1. Lactobacillus plantarum BC299 can Alleviate Dextran Sulfate Sodium-induced Colitis by Regulating Immune Response and Modulating Gut Microbiota
      Jingqi Zhao Tianjin University of Science and Technology, China
    • O5-2. Functional aspects of Weissella confusa F213 on chemically-induced colitis animal models
      Ni Nengah Dwi Fatmawati Universitas Udayana/Sanglah General Hospital, Indonesia
    • O5-3. Effects of the selected probiotics on improving growth performance, fecal noxious gas emissions and carcass characteristics of grow-finishing pigs
      Yu Ting Sun National Taiwan University, Taiwan
    • O5-4. The anti-oxidative effects of Bifidobacterium longum BB536 in Caenorhabditis elegans and in vitro -The anti-aging mechanism of BB536-
      Kazuya Toda Morinaga Milk Industry Co., Ltd., Japan
    • O5-5. Psychobiotic consumption relieved mental symptoms of major depression disorder patients and mice possibly via regulating gut microbiota and tryptophan metabolism
      Gang Wang Jiangnan University, China
    • O5-6. Lactobacillus plantarum GKM3 achieved memory retention, anti-oxidation, and promoted longevity in aged-accelerated mice
      You-Shan Tsai Grape King Bio Co. Ltd., Taoyuan, Taiwan

  • 13:39-13:50(0:11)

    Break Time

  • 13:50-14:50(1:00)

    Sponsor presentation A (20′ x 3)
    (Chair: Dr. Takane Katayama)

    • SA-1. Exploring the bacterial localization in intestine: Specific intestinal bacteria monopolize specific dietary nutrients
      Dr. Yusuke Nagara Yakult Central Institute, Japan
    • SA-2. Human-Residential Bifidobacteria (HRB) and human health – What the latest science says?
      Dr. Chyn Boon Wong Morinaga Milk Industry Co., Ltd., Japan
    • SA-3. Safety and efficacy of a Bifidobacterium lactis BL-99 and a Lacticaseibacillus paracasei subsp. paracasei strain K56 (+Movie Company Introduction)
      Dr. Wei-Hsien Liu Inner Mongolia Yili Industrial Group Co., Ltd., China

  • 14:50-15:05(0:15)

    Break Time

  • 15:05-16:05(1:00)

    Keynote Lecture 2 (50+10′): ‘Biotic’ family: definitions and future perspectives
    (Chair: Dr. Tadao Saito)

    • Prof. Seppo Salminen University of Turku, Finland

  • 16:05-16:20(0:15)

    Break Time

  • 16:20-18:50(2:30)

    Symposium 5 (20+5′ x 6): Microbial Metabolite and Cross-talk of Gut microbiota
    (Chair: Dr. Jiro Nakayama, Dr. Ming-Ju Chen)

    • S5-1. Gut microbiome and metabolome of Asian population related to diet and health
      Prof. Dr. Jiro Nakayama Kyushu University, Japan
    • S5-2. Gut microbiota and host health as revealed by the interaction between bile acids and gut microbes
      Prof , Dr. Atsushi Yokota Hokkaido Univiersity, Japan
    • S5-3. Functions of polyamines produced by intestinal microbiome
      Dr. Mitsuharu Matsumoto Kyodo Milk Industry Co. Ltd., Japan
    • S5-4. Targeting the gut microbiome as a treatment for cardiovascular diseases
      Prof. Dr. Ming-Ju Chen National Taiwan University, Taiwan
    • S5-5. Microbes and the host response to drugs
      Dr. Ratha Mahendran National University of Singapore, Singapore
    • S5-6. Bacterial-surface architecture and host colonization
      Asoc. Prof. Dr. Keita Nishiyama Keio University School of Medicine, Japan

  • 18:50-19:00(0:10)

    Break Time

  • 19:10-19:30(0:20)

    Closing Ceremony
    Award Ceremony for the Best Presentation by Young Scientists, ACLAB Flag Handover to ACLAB12

Channel 2

  • 12:15-13:39(1:24)

    Oral Presentation 6 (10+4′ x 6) Genetics and Genomics, others
    (Chair: Dr. Hiroshi Makino, Dr. Kenji Okano)

    • O6-1. Characterization of probiotic properties of bacteria isolated from bee’s gut from the northern of Thailand
      Siam Popluechai Mae Fah Luang University, Thailand
    • O6-2. Comparative studies of organic acids composition and the functional characteristics exerted by postbiotic metabolites derived from six strains of Lactiplantibacillus plantarum
      Laiella Shaahierra Jann Hishamuddin Universiti Putra Malaysia, Malaysia
    • O6-3. Quality Characteristics and Viability of Probiotics in Synbiotic Purple Yam Yogurt during Storage
      Lotis Escobin Mopera University of the Philippines Los Banos, Philippine
    • O6-4. Storage stability, sugar fermentation, and in vitro gastrointestinal tolerance of Bifidobacterium longum grown in sugar systems with inulin and fructooligosaccharide supplementation.
      Priyanka Parhi Monash University, Malaysia
    • O6-5. Comparative genomic and functional analysis of Lacticaseibacillus rhamnosus GG
      Ruipeng Wang Takanashi Milk Products Co., Ltd., Japan
    • O6-6. Bacterial changes associated with the rpsL gene mutation in Lacticaseibacillus rhamnosus GG
      Masami Tsukagoshi Shinshu University, Japan

  • 13:39-13:50(0:11)

    Break Time

  • 13:50-14:50(1:00)

    Sponsor presentation B (20′ x 3)
    (Chair: Dr. Keita Nishiyama)

    • SB-1. Evidence-Based Health Effects of Human Probiotic Fermented Yoghurt
      Dr. Lijun Chen Beijing Sanyuan Food Co., Ltd., Beijing, China
    • SB-2. Drug Discovery Applications of Gut Microbial Fatty Acid Metabolites
      Dr. Yasunori Yonejima Noster Inc., Japan
    • SB-3. Visceral fat reducing effect of Lactobacillus gasseri SBT2055
      Dr. Yasuyuki Seto MEGMILK SNOW BRAND Co., Ltd., Japan

  • 14:50-15:05(0:15)

    Break Time

  • 16:05-16:20(0:15)

    Break Time

  • 16:20-18:50(2:30)

    Symposium 6 (20+5′ x 6): Pre, Pro, Postbiotics and New Technology
    (Chair: Dr. Akihito Endo, Dr. Francisco Elegado)

    • S6-1. Genome-based taxonomy of the “Lactobacillus”
      Prof. Dr. Koichi Watanabe National Taiwan University, Taiwan
    • S6-2. Fructooligosaccharide metabolism in human commensal butyrate producers
      Prof. Dr. Akihito Endo Tokyo Univerisity of Agriculture, Japan
    • S6-3. Use of in vitro fecal culture for the screening and selection of probiotics and prebiotics for specific population groups: obesity as an example
      Prof. Dr. Miguel Gueimonde Spanish National Research Council, Spain
    • S6-4. Probiotic and dietary approaches for asymptomatic covid-19 patients
      Prof. Dr. Endang S. Rahayu Gadjah Mada University, Indonesia
    • S6-5. Plant-based LAB for the Development of Non-Dairy Probiotics
      Prof. Dr. Francisco B. Elegado University of Philippines Los Baños, Philippine
    • S6-6. Antimicrobial peptides produced by bifidobacteria in infant lamb
      Prof. Dr. Erdene Bayar Mongolian University of Life Science, Mongolia
PAGETOP